Description
Details
PureStem® ES-139 Progenitor expresses tumor necrosis factor (ligand) superfamily, member 18 (TNFSF18), heart and neural crest derivatives expressed 2 (HAND2), RNU2, GPR116, SPINK1, KRT86, GABRB1 (gamma-aminobutyric acid (GABA) A receptor, beta 1), and INS-IGF insulin- insulin-like growth factor 2. The most distal HOX gene expression is HOXA2, B2. This clonal human embryonic progenitor line was derived from the registered parental hES cell line H9.
Propagation Potential
PureStem Progenitor ES-139, is sold at passage 12 (the original clonal isolate confluent in a 1.9 cm2 well was P1), which corresponds to approximately 13.5 doublings since the first 1.9 cm2 well and approximately 31.5 doublings since its original clonal plating.
Propagation Potential
PureStem Progenitor ES-139, is sold at passage 12 (the original clonal isolate confluent in a 1.9 cm2 well was P1), which corresponds to approximately 13.5 doublings since the first 1.9 cm2 well and approximately 31.5 doublings since its original clonal plating.
Details
Details
| Quality Control | This line is negative for HIV (1, 2), HBV, HCV, bacteria, mycoplasma, and fungal contamination. Certificates of analysis are available on request. |
|---|---|
| Technical Documents | ES-139 Technical Data Sheet |
| References | West MD, et al. (2008) The ACTCellerate initiative: large-scale combinatorial cloning of novel human embryonic stem cell derivatives. Regen Med. 3(3):287-308. PMID: 18462054 |
Reviews
Write Your Own Review
Tags
Key Resources
More Information